May 2016

Dear shareholders and prospective shareholders,

Last Thursday we announced a significant transaction, with the acquisition of AGAA, an Austin, Texas based anesthesia company. More information about the specifics of the transaction can be found HERE.

Marketing & the Bloom Burton Conference

At the beginning of May, CRH attended the Bloom Burton Healthcare Investor Conference in Toronto. Held on May 2nd and 3rd, it is the preeminent healthcare investor conference in Canada. Our CEO, Edward Wright presented to a room of investors and fielded questions about our current operations and growth strategy moving forward. As part of the conference schedule, we also had the opportunity to meet 1-on-1 with institutional investors and provide more detail about how CRH intends to continue to execute our strategy.

In addition to attending the conference, we spent time marketing to accounts in Toronto outside of the organized conference meetings. Management met with new and existing institutional firms, and I spent time meeting with current and prospective shareholders from the retail investment community.

Our track record of executing on our strategic plan and our consistent operating results is resonating with the investment community. Our job is to educate investors on the opportunity in front of CRH to grow both the service and product sides of our business.

GI Conferences

This past month, CRH attended Digestive Disease Week (DDW) which was held in San Diego, CA. This meeting brings together approximately 14,000 individuals from across the U.S and around the world. The CRH O’Regan System was featured in the hemorrhoid therapies “hands-on” course put on by the American Society of Gastrointestinal Endoscopy for registered gastroenterologists. We also spent 3 days in the exhibit hall meeting with both new physicians as well as existing customers and continuing to spread the word about the CRH O’Regan System and CRH Anesthesia. We were able to garner a number of new leads for both business and look forward to attending again next year.

If you have any questions or would simply like a general update, don’t hesitate to contact me. Thank you for your continued support and we look forward to updating you again in a month’s time.

David Matousek
Director, Investor Relations
CRH Medical Corporation
T: 800.660.2153 x 1030
W: www.crhmedcorp.com
E: dmatousek@crhmedcorp.com

We're a stable, profitable company respected by both patients and physicians. Learn more »